These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19188852

  • 1. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF, Guthrie JR, Politi M, Dennerstein L.
    Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
    [Abstract] [Full Text] [Related]

  • 2. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L, Brynhildsen J, Hoffman M, Hammar M.
    Menopause; 2009; 16(6):1213-7. PubMed ID: 19455070
    [Abstract] [Full Text] [Related]

  • 3. Hot flushes during the menopause transition: a longitudinal study in Australian-born women.
    Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG.
    Menopause; 2005; 12(4):460-7. PubMed ID: 16037762
    [Abstract] [Full Text] [Related]

  • 4. Symptoms reported by women in midlife: menopausal transition or aging?
    Berecki-Gisolf J, Begum N, Dobson AJ.
    Menopause; 2009; 16(5):1021-9. PubMed ID: 19546824
    [Abstract] [Full Text] [Related]

  • 5. Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.
    Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I.
    Climacteric; 2006 Feb; 9(1):49-58. PubMed ID: 16428125
    [Abstract] [Full Text] [Related]

  • 6. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC).
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [Abstract] [Full Text] [Related]

  • 7. Health care-seeking for menopausal problems.
    Guthrie JR, Dennerstein L, Taffe JR, Donnelly V.
    Climacteric; 2003 Jun; 6(2):112-7. PubMed ID: 12841881
    [Abstract] [Full Text] [Related]

  • 8. Age, pattern and symptoms of menopause among rural women of Lahore.
    Yahya S, Rehan N.
    J Ayub Med Coll Abbottabad; 2002 Jun; 14(3):9-12. PubMed ID: 12476855
    [Abstract] [Full Text] [Related]

  • 9. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM, Korenstein D, Halm EA.
    Menopause; 2007 Jun; 14(2):216-22. PubMed ID: 17179789
    [Abstract] [Full Text] [Related]

  • 10. Modeling women's health during the menopausal transition: a longitudinal analysis.
    Dennerstein L, Lehert P, Guthrie JR, Burger HG.
    Menopause; 2007 Jun; 14(1):53-62. PubMed ID: 17023873
    [Abstract] [Full Text] [Related]

  • 11. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
    Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C.
    Menopause; 2003 Jun; 10(6):507-15. PubMed ID: 14627858
    [Abstract] [Full Text] [Related]

  • 12. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH.
    Health Qual Life Outcomes; 2005 Aug 05; 3():47. PubMed ID: 16083502
    [Abstract] [Full Text] [Related]

  • 13. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
    Thurston RC, Sowers MR, Chang Y, Sternfeld B, Gold EB, Johnston JM, Matthews KA.
    Am J Epidemiol; 2008 Jan 01; 167(1):78-85. PubMed ID: 17881385
    [Abstract] [Full Text] [Related]

  • 14. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?
    Greendale GA, Gold EB.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():148-54. PubMed ID: 16414341
    [Abstract] [Full Text] [Related]

  • 15. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I, Kealy R, Edwards R, Forbes J, Cuzick J.
    J Clin Oncol; 2006 Aug 20; 24(24):3991-6. PubMed ID: 16921052
    [Abstract] [Full Text] [Related]

  • 16. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009 Aug 20; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 17. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study.
    Haimov-Kochman R, Barak-Glantz E, Ein-Mor E, Arbel R, Brzezinski A, Milwidsky A, Hochner-Celnikier D.
    Hum Reprod; 2006 Sep 20; 21(9):2450-4. PubMed ID: 16731546
    [Abstract] [Full Text] [Related]

  • 18. Vasomotor symptoms in menopause: where we've been and where we're going.
    Pinkerton JV, Zion AS.
    J Womens Health (Larchmt); 2006 Mar 20; 15(2):135-45. PubMed ID: 16536677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.